MDM2 gene amplification: a new independent factor of adverse prognosis in non-small cell lung cancer (NSCLC).
Dworakowska D, Jassem E, Jassem J, Peters B, Dziadziuszko R, Zylicz M, Jakóbkiewicz-Banecka J, Kobierska-Gulida G, Szymanowska A, Skokowski J, Roessner A, Schneider-Stock R.
Dworakowska D, et al. Among authors: skokowski j.
Lung Cancer. 2004 Mar;43(3):285-95. doi: 10.1016/j.lungcan.2003.09.010.
Lung Cancer. 2004.
PMID: 15165086